HomeNews

News

The plant of Nanolek is about to launch production of the third Covivac vaccine

Nanolek uses a traditional technology to produce this vaccine containing an inactivated virus that triggers a potent immune response.

EMA approves new site for manufacture of Moderna Covid-19 vaccine in France

The European Medicines Agency (EMA) announced on June 11, 2021 that its committee for human medicines (CHMP) has approved a new manufacturing site for the...

Bayer builds a new pharmaceutical facility in Finland

Bayer is building a new pharmaceutical facility in Turku and at the same time modernizing its existing production plant. The new production facility will...

Tatyana Golikova: Russia should minimize imports of medicines

Russia should minimize its dependence on imports of ready-made medicines and pharmaceutical substances, Russian Deputy Prime Minister Tatyana Golikova said on Thursday. /TASS/ "In 2020,...

Vaxzevria: EMA advises against use in people with history of capillary leak syndrome

EMA’s safety committee (PRAC) has concluded that people who have previously had capillary leak syndrome must not be vaccinated with Vaxzevria (formerly COVID-19 Vaccine...

Egyptian company SOLYPHAR will build a pharmaceutical company in Uzbekistan

It is envisaged to implement the project in three stages from 2021 to 2024, the amount of investment from the company "SOLYPHAR" will be more than 20 million US dollars, in accordance to the international GMP standards.
spot_img

Expert Articles

spot_img